SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-18-015707
Filing Date
2018-11-14
Accepted
2018-11-14 12:54:42
Documents
55
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0918_americanbrivision.htm 10-Q 417012
2 CERTIFICATION f10q0918ex31-1_american.htm EX-31.1 14274
3 CERTIFICATION f10q0918ex31-2_american.htm EX-31.2 14320
4 CERTIFICATION f10q0918ex32-1_american.htm EX-32.1 5175
5 CERTIFICATION f10q0918ex32-2_american.htm EX-32.2 5353
  Complete submission text file 0001213900-18-015707.txt   2696894

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE abvc-20180930.xml EX-101.INS 406239
7 XBRL SCHEMA FILE abvc-20180930.xsd EX-101.SCH 34745
8 XBRL CALCULATION FILE abvc-20180930_cal.xml EX-101.CAL 38573
9 XBRL DEFINITION FILE abvc-20180930_def.xml EX-101.DEF 93155
10 XBRL LABEL FILE abvc-20180930_lab.xml EX-101.LAB 211411
11 XBRL PRESENTATION FILE abvc-20180930_pre.xml EX-101.PRE 176372
Mailing Address 11 SAWYERS PEAK DRIVE GOSHEN NY 10924
Business Address 11 SAWYERS PEAK DRIVE GOSHEN NY 10924 845-551-8728
American BriVision (Holding) Corp (Filer) CIK: 0001173313 (see all company filings)

IRS No.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-91436 | Film No.: 181182181
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1